Screener
IYH vs IDNA
iShares U.S. Healthcare ETF vs iShares Genomics Immunology and Healthcare ETF
Key differences
- IYH costs 0.09% less per year.
- IYH is significantly larger than IDNA — larger funds tend to be more liquid and less likely to close.
- Over the last 3 years, IDNA has delivered higher annualized returns.
- IYH has a longer track record, which may reduce uncertainty around long-term behavior.
Side-by-side comparison
| IYH | IDNA | |
|---|---|---|
| Annual cost (TER) | 0.38% | 0.47% |
| Fund size (AUM) | $2.8B | $160M |
| Since | 2000 | 2019 |
| Dividend yield | 1.31% | 1.05% |
| Asset class | equity | equity |
| Region | north america | — |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +16.1% | +49.2% |
| CAGR 3Y | +5.8% | +8.0% |
| CAGR 5Y | +4.8% | -7.5% |
| Sharpe 3Y | 0.22 | 0.29 |
| Volatility 1Y | 14.63% | 24.43% |
| Max drawdown | -28.40% | -68.26% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to IYH and IDNA
Explore further